S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
US Dollar Replaced By "Biden Bucks"? (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
High oil prices help Saudi Aramco earn $88B in first half
The Day of Financial Reckoning Is Near (Ad)
Germans urged to cap heat in offices this winter to save gas
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Former Deutsche Bank Co-CEO Anshu Jain dies
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
US Dollar Replaced By "Biden Bucks"? (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
High oil prices help Saudi Aramco earn $88B in first half
The Day of Financial Reckoning Is Near (Ad)
Germans urged to cap heat in offices this winter to save gas
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Former Deutsche Bank Co-CEO Anshu Jain dies
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
US Dollar Replaced By "Biden Bucks"? (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
High oil prices help Saudi Aramco earn $88B in first half
The Day of Financial Reckoning Is Near (Ad)
Germans urged to cap heat in offices this winter to save gas
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Former Deutsche Bank Co-CEO Anshu Jain dies
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
US Dollar Replaced By "Biden Bucks"? (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
High oil prices help Saudi Aramco earn $88B in first half
The Day of Financial Reckoning Is Near (Ad)
Germans urged to cap heat in offices this winter to save gas
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Former Deutsche Bank Co-CEO Anshu Jain dies
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
NASDAQ:CYRX

Cryoport - CYRX Stock Forecast, Price & News

$45.00
+1.40 (+3.21%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$43.64
$45.36
50-Day Range
$24.08
$45.00
52-Week Range
$19.82
$86.30
Volume
452,020 shs
Average Volume
365,463 shs
Market Capitalization
$2.18 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$61.33

Cryoport MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
36.3% Upside
$61.33 Price Target
Short Interest
Healthy
11.20% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.69mentions of Cryoport in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.80) to ($0.24) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.99 out of 5 stars

Transportation Sector

80th out of 125 stocks

Pharmaceutical Preparations Industry

403rd out of 557 stocks

CYRX stock logo

About Cryoport (NASDAQ:CYRX) Stock

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.

Cryoport Stock Performance

Shares of NASDAQ:CYRX opened at $45.00 on Friday. The company has a market capitalization of $2.18 billion, a price-to-earnings ratio of -7.28 and a beta of 1.13. The firm's 50 day simple moving average is $32.90 and its 200 day simple moving average is $31.36. The company has a debt-to-equity ratio of 0.73, a current ratio of 14.21 and a quick ratio of 13.69. Cryoport has a fifty-two week low of $19.82 and a fifty-two week high of $86.30.

Cryoport (NASDAQ:CYRX - Get Rating) last announced its earnings results on Thursday, August 4th. The consumer goods maker reported ($0.23) EPS for the quarter, missing the consensus estimate of ($0.15) by ($0.08). The company had revenue of $64.20 million for the quarter, compared to analyst estimates of $64.58 million. Cryoport had a negative return on equity of 14.43% and a negative net margin of 125.96%. The business's quarterly revenue was up 14.2% on a year-over-year basis. During the same quarter last year, the business posted ($0.16) earnings per share. As a group, sell-side analysts forecast that Cryoport will post -0.8 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. Roth Capital cut their target price on shares of Cryoport from $90.00 to $67.00 in a research note on Tuesday, May 3rd. Needham & Company LLC increased their price objective on shares of Cryoport from $41.00 to $42.00 and gave the stock a "buy" rating in a report on Tuesday, July 12th. KeyCorp cut their target price on shares of Cryoport from $92.00 to $52.00 in a research report on Friday, May 6th. B. Riley cut their target price on shares of Cryoport from $61.00 to $55.00 in a research report on Tuesday, May 17th. Finally, BTIG Research cut their price target on shares of Cryoport from $95.00 to $60.00 in a research report on Friday, May 6th. Six equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, Cryoport currently has a consensus rating of "Buy" and an average price target of $61.33.

Receive CYRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter.

CYRX Stock News Headlines

CYRX Crosses Above Key Moving Average Level
Analysts Anticipate EZM Will Reach $61
Cryoport Reports Results for the Second Quarter 2022
CryoPort's Earnings: A Preview - Benzinga
Daseke (DSKE) Q2 Earnings Lag Estimates
What 4 Analyst Ratings Have To Say About CryoPort
See More Headlines
Receive CYRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter.

CYRX Company Calendar

Last Earnings
8/04/2022
Today
8/14/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CYRX
Employees
791
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$61.33
High Stock Price Forecast
$92.00
Low Stock Price Forecast
$42.00
Forecasted Upside/Downside
+36.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Net Income
$-275,530,000.00
Net Margins
-125.96%
Pretax Margin
-125.59%

Debt

Sales & Book Value

Annual Sales
$222.61 million
Book Value
$11.43 per share

Miscellaneous

Free Float
43,786,000
Market Cap
$2.18 billion
Optionable
Optionable
Beta
1.13














CYRX Stock - Frequently Asked Questions

Should I buy or sell Cryoport stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cryoport in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CYRX shares.
View CYRX analyst ratings
or view top-rated stocks.

What is Cryoport's stock price forecast for 2022?

6 equities research analysts have issued 12-month target prices for Cryoport's shares. Their CYRX share price forecasts range from $42.00 to $92.00. On average, they anticipate the company's share price to reach $61.33 in the next twelve months. This suggests a possible upside of 36.3% from the stock's current price.
View analysts price targets for CYRX
or view top-rated stocks among Wall Street analysts.

How have CYRX shares performed in 2022?

Cryoport's stock was trading at $59.17 at the beginning of 2022. Since then, CYRX stock has decreased by 23.9% and is now trading at $45.00.
View the best growth stocks for 2022 here
.

When is Cryoport's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our CYRX earnings forecast
.

How were Cryoport's earnings last quarter?

Cryoport, Inc. (NASDAQ:CYRX) issued its quarterly earnings data on Thursday, August, 4th. The consumer goods maker reported ($0.23) EPS for the quarter, missing the consensus estimate of ($0.15) by $0.08. The consumer goods maker earned $64.20 million during the quarter, compared to analysts' expectations of $64.58 million. Cryoport had a negative trailing twelve-month return on equity of 14.43% and a negative net margin of 125.96%. The business's revenue was up 14.2% on a year-over-year basis. During the same quarter last year, the firm earned ($0.16) EPS.

What guidance has Cryoport issued on next quarter's earnings?

Cryoport updated its FY 2022 earnings guidance on Thursday, August, 11th. The company provided EPS guidance of for the period. The company issued revenue guidance of $260.00 million-$265.00 million, compared to the consensus revenue estimate of $260.62 million.

What other stocks do shareholders of Cryoport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryoport investors own include Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Amarin (AMRN), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Pfizer (PFE) and Block (SQ).

What is Cryoport's stock symbol?

Cryoport trades on the NASDAQ under the ticker symbol "CYRX."

Who are Cryoport's major shareholders?

Cryoport's stock is owned by many different institutional and retail investors. Top institutional shareholders include Victory Capital Management Inc. (2.83%), Clearbridge Investments LLC (2.50%), Massachusetts Financial Services Co. MA (2.13%), Granite Investment Partners LLC (1.86%), Northern Trust Corp (1.74%) and abrdn plc (1.56%). Insiders that own company stock include Daniel M Hancock, Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Jerrell Shelton, Mark W Sawicki, Michael R Egeck, Richard J Berman and Robert Stefanovich.
View institutional ownership trends
.

How do I buy shares of Cryoport?

Shares of CYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cryoport's stock price today?

One share of CYRX stock can currently be purchased for approximately $45.00.

How much money does Cryoport make?

Cryoport (NASDAQ:CYRX) has a market capitalization of $2.18 billion and generates $222.61 million in revenue each year. The consumer goods maker earns $-275,530,000.00 in net income (profit) each year or ($6.18) on an earnings per share basis.

How many employees does Cryoport have?

The company employs 791 workers across the globe.

How can I contact Cryoport?

Cryoport's mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The official website for the company is www.cryoport.com. The consumer goods maker can be reached via phone at (949) 470-2300, via email at tfromer@kcsa.com, or via fax at 949-470-2306.

This page (NASDAQ:CYRX) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.